Forefront Analytics, LLC Dr Reddys Laboratories LTD Transaction History
Forefront Analytics, LLC
- $209 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
232Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$155 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$154 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$153 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$150 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$135 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.5B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...